VT News
Angélica Lozano Correa

Angélica Lozano Correa

Ask VT AI
View News Summary
  • Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.
  • Agentic AI is transforming the market, driving intense competition for talent and startups, and demanding operational rigor to scale reliably, while governance is urged to keep pace and mitigate risks.
  • NBA teams adjust starting lineups amid key player injuries ahead of crucial matchups.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.
  • Agentic AI is transforming the market, driving intense competition for talent and startups, and demanding operational rigor to scale reliably, while governance is urged to keep pace and mitigate risks.
  • NBA teams adjust starting lineups amid key player injuries ahead of crucial matchups.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Angélica Lozano Correa

Top Topics

Trending in U.S.

World

Sport